Overview
Mentions in press and media 14
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 9, 2025 | P-Cure Expands Production Capacity in Israel with New Dedicated Facility Focused on Compact Proton Therapy Accelerator Manufacturing | P-Cure opens its second production facility in Israel. P-Cure, a global innovator in compact proton therapy solutions, has announced the inauguration of its second production facility in Israel. JERUSALEM, Israel, June 9, 2025 /PRNewswire-P... |
| Jan 23, 2025 | P-Cure Announces Routine Implementation of Proton ARC Therapy by Jerusalem-based Hadassah Medical Center | ARC treatment planning for proton therapy in order to deliver a continuous, conformal dose while accounting for anatomical organ motion, resulting in minimal exposure to healthy tissue. P-Cure, a global leader in precision oncology, proudly... |
| Sep 3, 2024 | P-Cure Announces the Appointment of Dr. John Wong to its Scientific Advisory Board Supporting its Innovative Growth Strategy | Dr. John Wong joins P-Cure Scientific Advisory Board. Dr. John Wong joins P-Cure Scientific Advisory Board TEL AVIV, Israel, Sept. 3, 2024 /PRNewswire-PRWeb/ -- Dr. John Wong, as a new Board Member, will help P-Cure to incorporate cutting e... |
| May 5, 2024 | Brazilian Doctor Ushering in New Era of Medical Technology for Treating Cancer and Seeks to Bring Proton Therapy to Brazil | Dr. Marcel Fang at the P-Cure Proton Therapy facility. He hopes to bring this medical technology to Brazil. A native born and trained Brazilian oncologist is in the forefront of a new era in the treatment of cancer patients with cutting edg... |
| Mar 4, 2024 | Radiotherapy Market Trends, Size, Share, Growth, Advancements, Innovations and Forecast 2030 | Radiotherapy Market Radiotherapy Market to Surpass USD 9.44 Billion by 2030 Driven by Increasing Cancer Incidence and Government Initiatives AUSTIN, TEXAS, UNITED STATES, March 4, 2024 /EINPresswire.com/ -- According to SNS Insider, the Rad... |
| Oct 1, 2023 | RaySearch deepens collaboration with P-Cure | RaySearch deepens collaboration with P-Cure Sun, Oct 01, 2023 12:00 CET Report this content RaySearch Laboratories AB (publ) is pleased to announce its expanded collaboration with P-Cure, aiming at enhancing the workflow efficiency of P-Cur... |
| Oct 1, 2023 | Cure Opens New Era of Proton Therapy with FDA Anatomical Site Clearance for Compact, Affordable System with Clinical Advantages Fitting Linac Rooms | A new era in the treatment of cancer with proton therapy is being ushered in by the P-Cure development of a proton system. SHILAT, Israel, Sept. 30, 2023 /PRNewswire-PRWeb/ -- A new era in the treatment of cancer with proton therapy is bein... |
| Jun 26, 2023 | P-Cure, in Cooperation with Hadassah Medical Center, Completes Treatment Of First Patient Using World’s Most Compact, Patient Centric, Proton Therapy System | “The solution is the most compact comprehensive proton therapy system that simulates, plans, positions, and treats with enhanced patient comfort and clinical results, treating all indications with adaptive, personalized proton therapy proto... |
| Apr 3, 2023 | P-Cure Receives FDA Approval For Proton Therapy System For Treatment in Seated Position and Will Begin Treating Patients In Israel | P-Cure announced today clearance of its Adaptive Proton Therapy Solution by the FDA for sales in the USA. P-Cure, an Israel-based high-med-tech company, has developed affordable proton therapy technology for targeted treatment of cancer wit... |
Reviews 0
FAQ about p-cure.com
What has the press written about p-cure.com?
Parsers VC has collected 14 articles mentioning p-cure.com, among them “P-Cure Expands Production Capacity in Israel with New Dedicated Facility Focused on Compact Proton Therapy Accelerator Manufacturing” (Jun 9, 2025) and “P-Cure Announces Routine Implementation of Proton ARC Therapy by Jerusalem-based Hadassah Medical Center” (Jan 23, 2025).
Is p-cure.com still active?
Yes, p-cure.com is active; its latest activity on Parsers VC dates from Sep 16, 2026.